Why the study?
Does a staged versus simultaneous approach to thoracoscopic hybrid ablation improve time to recurrence of atrial arrhythmia in patients with persistent atrial fibrillation?
Does a staged versus simultaneous approach to thoracoscopic hybrid ablation improve time to recurrence of atrial arrhythmia in patients with persistent atrial fibrillation?
In patients with persistent AF undergoing hybrid ablation, a staged approach increases the detection of incomplete PVI but does not improve freedom from atrial arrhythmia recurrence compared to a same-day procedure.
Answers are grounded in this paper and cite their sources.
Similar recurrence rates after staged versus simultaneous hybrid ablation; leaves open optimal procedural timing in persistent AF.
INTRODUCTION: Totally thoracoscopic (TT) epicardial ablation combined with endocardial catheter ablation is an emerging treatment for persistent AF. The effects of timing of the TT and endocardial portion on AT/AF recurrence are not known. METHODS: We retrospectively analyzed patients undergoing TT staged versus simultaneous hybrid AF ablation at our institution. Arrhythmia-free outcome was compared using time to recurrence (AF or AT greater than 30 seconds after a 3-month blanking period from endocardial ablation) at 12 months. All subjects had continuous ILR or PM monitoring. RESULTS: Eighty-three patients (52 same-day, 31 staged) underwent TT hybrid AF ablation. Recurrence was observed in 23 (29%) patients at a median time of 147 days (IQR 91,238). In univariate analysis, a staged approach significantly increased the likelihood of detecting incomplete PVI (OR 6 [95% CI 2-17] P = 0.001). However, only longstanding persistent AF (LSP-AF) status predicted recurrence (HR 4 [95% CI 1.4-12] P = 0.01). Neither a staged approach (HR 1.0 [95% CI 0.4-2.4] P = 0.9), nor detection of incomplete PVI (HR 0.9 [95% CI 0.4-2.3] P = 0.8) predicted time to first AF/AT recurrence. CONCLUSIONS: Staged hybrid ablation of AF significantly increases the likelihood of discovering incomplete PVI at the time of endocardial mapping versus a same-day procedure. However, the staged approach did not improve time to first AT/AF recurrence.
No takes yet. Share an insight, caveat, or question.
Richardson et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: